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Introduction
Count distributions arise in a number of fields relevant to medicine, and typically present different challenges for analysis than those encountered with continuous distributions, particularly where the mean count is close to zero and the observations are over-dispersed compared to the Poisson distribution. One such challenge arises when assessing the effect of interventions for countable phenomena such as criminal activities 1,2 , migraines 3 , falls in elderly patients 4 , seizures 5, 6 , MRI lesion counts 7 and intestinal parasites [8] [9] [10] , where the latter are quantified using counts of parasite eggs in stool. We define the problem first in general terms, and then with a motivating example.
Let µ1 and µ2 denote the mean of two over-dispersed count datasets representing the comparator and treatment group, respectively. The ratio of µ2 to µ1 is the parameter of interest when measuring the effect of an intervention evaluated against either an alternative treatment or an untreated control.
We consider two common study designs: those comparing paired sets of observations from the same individuals before and after treatment (paired data), and those comparing a single set of observations from individuals assigned to different treatment/control groups (unpaired data). In both of these cases, it is useful to compare r = 1 -µ2 / µ1 to a pre-specified target, but there is currently no clearly-justified statistical framework within which summary statistics and confidence intervals can be interpreted, except in the simplest case when testing that µ1≠ µ2 7, 11, 12 . We note that our focus is fundamentally different from that of the standard hypothesis of equality; we aim to investigate simultaneously two related but distinct questions: 1) Is r low enough to conclude that the intervention demonstrates evidenced inadequacy?
2) Is r high enough to conclude that the intervention demonstrates evidenced adequacy?
Our motivating example is the analysis of egg reduction rate data (ERR; also known as faecal egg count reduction or FECR) in order to evaluate the efficacy of an anthelmintic treatment against intestinal parasites. Such data is most frequently collected in a paired experimental design, but unpaired studies comparing randomised treatment/control groups are possible, and a combination of the two situations, whereby multiple treatment arms result in multiple paired datasets (one for each treatment arm), are also encountered e.g. 13, 14 . In the paired study design, pre-treatment stool samples are obtained from individuals enrolled in the study and the number of parasite eggs within a fixed volume of stool is enumerated. A number of days after the administration of an anthelmintic treatment, a post-treatment stool sample is obtained from each of the individuals, and the number of parasite eggs within a fixed quantity of stool is again enumerated 15 . One statistic of interest is the ERR, which is defined as one minus the ratio of arithmetic means between the pre-treatment data (µ1) and post-treatment data (µ2), thus reflecting the average efficacy of the drug in these individuals. An alternative statistic of interest is the cure rate, although we consider only the ERR here because the cure rate is arguably less appropriate for assessing drug efficacy 9, 16 . Typically, the goal of quantifying the ERR is either to assess the efficacy of novel anthelminthic treatments or regimens 13 , or to provide evidence for reduced efficacy compared to the published expected efficacy of the same drug in a naïve population, i.e. to determine if either anthelmintic resistance is present or the drugs being used are of poor quality 9, 10, 17 . Although the World Health Organisation guidelines 18 only discuss the use of point estimates, the standard approach to analysis within the medical literature is to generate 95% confidence intervals for the drug efficacy using a nonparametric bootstrap 13, 19 . In veterinary parasitology, a variety of parametric approximation methods are used, such as that given by Coles et al. 20 and later expanded by Pepper et al. 21 , the method of Levecke et al. 10 , and the method of Dobson et al. 22 . However, only one of these methods can be used when the observed efficacy equals 100% due to the post-treatment mean and variance of zero.
Alternative methods have been suggested based on Markov chain Monte Carlo (MCMC) [23] [24] [25] [26] , but the correct use of such computationally intensive methods requires statistical and computational skills and training that may be out of scope for the typical practitioner 27 .
In addition to the lack of a standardised method to calculate 95% confidence intervals, there is also a current lack of consensus regarding the interpretation of results based on these confidence intervals. In a veterinary parasitology conference abstract, Pepper et al. 21 used a simulation study to explore different interpretations and concluded that there were a number of inadequacies in standard approaches, arising from the failure to quantify and incorporate uncertainty. They recommended using a test of inferiority, i.e. a one-sided test of r compared to a pre-specified target value. They also noted the importance of powering studies appropriately, given what they perceived as a low probability of detecting situations where the true efficacy was below the target. Accordingly, the same authors used a framework based on an inferiority test to interpret a simulation study 28 .
However, these studies are based on the empirical performance of different classification methods rather than a rigorous justification of the underlying statistical issues. To the authors' knowledge, no such justification currently exists in either the medical or veterinary parasitology literature, or elsewhere within related fields.
Our objective is therefore to outline and justify a statistical framework to evaluate the ratio of means between two data series drawn from negative binomial distributions. We implement this framework along with three currently available statistical tests, as well as two novel statistical methods, and compare the statistical properties of these methods by use of simulation. We illustrate our approach by analysing ERR data from one arm of a randomised controlled trial representing the efficacy of the anthelmintic mebendazole against three intestinal parasites in children; hookworm, Ascaris lumbricoides and Trichuris trichiura.
Data
Our analytical methods are illustrated using a dataset obtained from a randomised controlled trial in children on Pemba Island, Tanzania, which is registered at ClinicalTrials.gov (NCT03245398) and has previously been described by Palmeirim et al. 14 
The purpose of the original study was to compare single-dose and multiple-dose mebendazole treatment, but for the purposes of this manuscript, we only use data from the 91 individuals who completed the study according to the protocol for single-dose mebendazole treatment. Two stool samples were taken from each child on different days, and were examined by preparing and screening duplicate Kato-Katz thick smears 29 for each stool sample (each Kato-Katz thick smears represents approximately 41.7 mg of stool).
The slides were examined under a light microscope and the total count over the four slides for each child was then recorded for the eggs of three parasites (hookworm, A. lumbricoides and T. trichiura). All 91 children were positive for hookworm at pre-treatment, 46 children were positive for A. lumbricoides, and 46 children were positive for T. trichiura. Each of the children was treated with the anthelmintic mebendazole before another two consecutive stool samples per subject were taken 14-21 days post-treatment and analysed as for the pre-treatment samples. This resulted in a total of 546 count observations from 91 individuals (two samples each relating to three parasites).
Although Palmeirim et al. 14 Levecke et al. 10 as: 70% for hookworm, 95% for A. lumbricoides and 50% for T. trichiura. The objective of this exercise was to evaluate the observed efficacy of the drug by comparing the observed ERR to these published target figures, so that the evidence for reduced anthelmintic efficacy in this population can be assessed.
Statistical framework
We propose a formal statistical framework that can be used to interpret the observed counts xi and yj in terms of the quantity of interest r = 1 -µ2 / µ1. Our example focuses on application to paired data, but we note that the framework also holds for use with unpaired data, either with treatment vs. control groups or with direct comparison between different treatment groups if the target efficacy is interpreted as the ratio of post-treatment mean counts between two treatment arms. If the purpose of the exercise is simply to establish estimates for r, then a straightforward point estimate and confidence interval associated with this estimator will suffice. However, we anticipate a further desire to classify the biological implications of the result according to a standardised interpretative framework illustrated by the two questions given in the introduction: 1) Is r low enough to conclude that the intervention demonstrates evidenced inadequacy?
We follow Pepper et al. 21 in suggesting that a one-sided inferiority test formulation is appropriate to address question (1), i.e. to assess whether there is statistically significant evidence that the observed mean efficacy is lower than desired. The most relevant location parameter against which to compare r for this purpose is a threshold TI equal to the expected efficacy E, e.g. 0.95 for A.
lumbricoides.
A test of superiority of the observed mean efficacy relative to an appropriate location parameter can be formulated in order to address question (2), although the authors are not aware of any previous study in which this has been done. In any case, we believe that a non-inferiority test is conceptually better justified. Such tests form part of the regulatory regime for producing generic pharmaceutical products, where it is necessary to show that the generics will not be appreciably worse than the original products [31] [32] [33] [34] . We believe that there is a clear parallel between this situation and the desire to demonstrate that the efficacy of an anthelmintic compound observed 'in the field' is not appreciably worse than the expected efficacy of the same drug. Such a hypothesis requires the definition of an additional quantity: the margin of equivalence d, which quantifies the idea of 'not appreciably worse' as used above. We note that the margin of equivalence in a non-inferiority test can be made arbitrarily small; if the margin is set to zero, then the properties of the non-inferiority test will be identical to those of a test of superiority. The margin of equivalence d can usefully be defined as the difference between the target efficacy E and the maximum value for r that would be tolerated as consistent with an effective intervention. For example, if E is taken as 0.95 for A.
lumbricoides and a non-inferiority threshold TA is defined as a minimum acceptable efficacy of 0.90, then d = 0.05. In a situation where two drugs are to be compared directly by randomisation of individuals between the drugs, then the natural choice for the target E is a value of 0, reflecting an identical efficacy between drugs (so that the expected ratio µ2 / µ1 is equal to 1), and the choice of d follows the standard procedure for equivalence testing 34 .
Based on these two tests, and assuming that interpretation of the results will depend on the positioning of lower and upper confidence interval estimates for r obtained via some valid statistical method, it is straightforward and instructive to consider the different possible typologies that might arise in practice ( Figure 1 ). There are ten different typologies in total, although these can be grouped into four typology groups based solely on the results of the two tests previously defined. It is important to note that previous interpretative approaches within the veterinary parasitology literature 20, 25, 28, 35 have used the point estimate as part of the classification system (which would require us to provide an interpretation of each of the ten typologies), but we reject this strategy and confidence intervals for r (red brackets), relative to the two thresholds TA (dashed line) and TI (solid line). Equivalent interpretations within typology groups are indicated using right braces. because it mixes two very different types of information relating to the population and the sample: the confidence interval, which quantifies uncertainty about the true underlying efficacy (population information), and the point estimate, which is simply a summary of what was observed in the study (sample information). For typologies 1a, 1b & 1c, the upper confidence bound for r is below the target TI , which is sufficient to conclude that the observed efficacy is statistically significantly inadequate, as defined previously. For typologies 4a, 4b & 4c, the lower confidence bound is above the target TA so we are able to conclude that r is statistically significantly adequate; typology 4c reflects the more extreme situation where r would be statistically significantly greater than the published naïve efficacy E, which may be unlikely to occur in practice. This illustrates the rationale behind using a non-inferiority hypothesis test within our framework; if a test of superiority were used instead, typology 4c would be the only situation in which the efficacy would be assessed as adequate. Typologies 2a, 2b & 2c reflect situations where the confidence interval for r is so wide that there is no evidence that the true value can be excluded from any of the parameter regions -a potential consequence of an inadequate sample size. Finally, typology 3 reflects a situation where there is statistically significant evidence that r lies between TA and TI, which can only occur when there is a sufficiently large sample size that the entire confidence interval is within these limits. The authors believe that it is appropriate for this typology to have a clear and distinct designation since, should it arise in practice, this would reflect a very specific situation: where there is statistically significant evidence that the treatment has less efficacy than the target, but where it is also within the specified margin of equivalence. In our motivating example, this would correspond to a biological interpretation of early stage and/or low-level reduction in drug efficacy due to e.g.
emerging anthelmintic resistance or sub-optimal drug quality.
We also note that it is not necessary to know the precise estimates of the confidence intervals to classify to the four topologies; only the binary results of the two comparisons of lower CL ≥ TA and upper CL < TI. We can therefore define the classifications via one-sided hypothesis tests, as follows: a. We can reject the null hypothesis that r < TA with p < 0.025
Where only one of these two criteria are met, the result should be used to categorise the result as either adequate efficacy (typology 4) or reduced efficacy (typology 1), respectively. These classifications are based on positive evidence of either acceptable or reduced efficacy. Where neither criterion is met, the result should be categorised as inconclusive (typology 2) on the basis that there is insufficient evidence to conclude either that r ≥ TA or that r < TI. We follow Torgersen et al. 24 and Geurden et al. 25 in the use of this inconclusive categorisation, which we believe is valuable given that sufficient evidence for the positive classifications defined above is not always available in practice. Depending on the sample size and chosen value of d, it is also possible for both criteria to be met: a further category, borderline efficacy (typology 3), is therefore defined to describe situations where there is statistical evidence that ! is below the threshold TI but also above the threshold TA.
Statistical methods

Notation and general remarks
The following terms are used throughout this section:
• efficacy: In this manuscript the term efficacy is simply used as a synonym for the arithmetic mean egg reduction rate (ERR), although we note that the parasitological definition of anthelmintic efficacy is a more complex issue.
• xi : A set of pre-treatment count observations from individuals i in 1 … N1, distributed according to a negative binomial distribution with mean µ1 and shape parameter k1.
• yj : A set of post-treatment count observations from individuals j in 1 … N2, distributed according to a negative binomial distribution with mean µ2 and shape parameter k2.
• paired data: A study design where if i = j, the observations xi and yj will have been collected from the same individual. In this case, we assume that N1 = N2.
• unpaired data: A study design where an observation of any individual i is assumed to be independent of subsequent observations of all individuals j. In this case, we do not necessarily assume that N1 = N2.
• r = 1 -µ2 / µ1 : The quantity of interest, representing the efficacy (ERR) of the treatment. : The maximum likelihood estimator of µ1 (and equivalently µ2).
• E : The target for r based on the expected effect of the intervention in optimal circumstances, which could be interpreted as full susceptibility to the anthelmintic compound, e.g. a target efficacy of 95% for A. lumbricoides would correspond to the expectation that µ2 ≤ (1-0.95)µ1 under a fully effective treatment.
• d : A non-inferiority margin below E indicating the minimum value of r that would be considered to be consistent with a fully efficacious intervention.
• TI = E : The inferiority test threshold.
• TA = E-d : The non-inferiority test threshold.
A number of methods have previously been proposed to generate 95% confidence intervals for the ratio of means between two count distributions: we briefly outline these below for the case of paired data, therefore assuming that N = N1 = N2. For simplicity, we will also assume that a single pre-treatment count and a single post-treatment count are available for each individual, but we note that each method can also be used after summing multiple pre-treatment and/or post-treatment observations for each individual. For example, where each xi consists of > 8 replicate count observations within individual i (e.g. duplicate or quadruplicate Katz Katz thick smears), then summing these replicate observations within each xi results in a Negative Binomial distribution with mean equal to > 8 • 7 8 and an over-dispersion parameter equal to > 8 • @ 8 36 .
If each yj consists of > A replicate count observations within individual j, then these can be summed in a similar manner. The analysis can then be performed on the sums of these replicate observations, conditional on the number of replicates > 8 being consistent across individuals i, and the number of replicates > A being consistent across individuals j.
Existing computationally simple methods
A normal approximation method is given in the appendix of Coles et al. 20 and later justified by Pepper et al. 21 . Using our notation, the upper and lower 95% confidence limits for r are given by
and t is the 97.5 percentile point for Student's t distribution with degrees of freedom equal to R − 1. The confidence intervals are indeterminate when ∑ S T = 0, and previous work has identified that egg count data in animals are not well approximated by a normal distribution 37 , although the method has empirically been shown to work well within a relatively narrow range of parameter values when ∑ S T > 0 23 . We refer to this as the World Association for the Advancement of Veterinary Parasitology or WAAVP method.
An alternative approximation based on the gamma distribution with parameters obtained using a delta method approximation is given by Levecke et al. 10 . The upper and lower 95% confidence limits for r are given by the 2.5 th and 97.5 th quantiles of the gamma distribution with parameters
and a represents the withinindividual correlation between pre-and post-treatment samples. We refer to this as the Gamma method.
An exact Bayesian method based on conjugate priors has been proposed by Dobson et al. 22 based on the method of estimating confidence intervals for a binomial proportion given by Brown et al. 38 .
Assuming that yi ~ Binomial(xi, 1-r) then the beta distribution can be used as a conjugate prior to fully describe the posterior as: This method requires definition of the parameters α0 and β0 in the prior, for which Dobson et al. 22 justify the use of values of 1 based on the empirical remark that it generates more conservative lower confidence intervals than the Jeffrey's priors of 0.5 suggested by Brown et al. 38 . This method ignores the correlation between paired : ; and S ; , and also assumes that the number of 'trials' is a fixed quantity, i.e. it does not model the potentially appreciable uncertainty in ∑ : ; . As a consequence, the confidence intervals generated are generally too narrow. Dobson et al. 22 note this based on empirical observations, and advocate the use of 99% confidence intervals in place of 95% confidence intervals to compensate for the effect. However, this method does not require that ∑ S T > 0, which is an important potential advantage. We refer to this as the Binomial method.
Asymptotic distribution of !̂
We note that the means of x and y will be asymptotically distributed as:
Where:
Then, using the delta method 39 , the maximum likelihood estimator for 1-r is asymptotically distributed as:
where,
The matrix x can be estimated as:
and using maximum likelihood estimators for 1 − !̂= S 5 :̅ Ç and 7 8 = :̅ , we obtain:
For paired data, it is also necessary to take account of the correlation between pre-and posttreatment samples from the same individual. We do this by scaling the variance estimates This allows for the calculation of asymptotically unbiased and efficient confidence intervals for r, but the estimates may be poor for small sample sizes. We refer to this as the Asymptotic method.
Exact distribution of an alternative test statistic
Although r is typically the parameter of interest, the hypothesis testing framework allows us to consider any related test statistic for which the expected distribution under the null hypotheses can be defined. As such, we note that ∑ àS T − S 5â
â is a potentially valid test statistic, and that:
where:
The quantities R A and r are fixed and defined by the null hypotheses, respectively. The quantities @ A and 7 8 = @ 8 8Xé , é , are unknown but can be estimated from the data. Following a similar rationale to that of Dobson et al. 22 , we note that the Bayesian posterior distribution of p1 can be defined using a beta conjugate prior:
Again, R 8 is known, and the prior quantities α0 and β0 can be set to take small values, reflecting a minimally informative prior belief for the parameter ç 8 . By taking an indefinite integral of these two distributions, the expected distribution of the test statistic can be approximated using a beta negative binomial distribution:
Where α2 and β2 can be calculated as non-linear functions of r, α0, β0, ∑ : ;
;<8 , R 8 , @ 8 and @ A (see the statistical appendix for further details). For paired data, it is necessary to take account of the correlation between pre-and post-treatment samples from the same individual. We do this by scaling the over-dispersion parameters @ 8 and @ A by 1 minus the correlation between paired : ; and S ; . This method accounts for uncertainty in 7 8 , but ignores uncertainty in @ 8 and @ A , which are simply taken as point estimates from the data (we calculate these by maximum likelihood). The impact of assuming that @ 8 and @ A are fixed is assessed by simulation in section 6. Where @ A cannot be estimated from the data (i.e. when ∑ S T + -T<8 = 0), then the additional simplifying assumption of @ A = @ 8 can be made, which permits the use of this method in the important case that ∑ S T = 0. We refer to this as the Beta Negative Binomial or BNB method. Unlike the other methods described above, the BNB method cannot be used to generate confidence intervals for r, but it can be used as the basis for hypothesis testing within the framework specified The classifications specified in section 3 can then be applied to the results of these p-values, with significance thresholds of p < 0.025 used here for equivalence with the use of 95% confidence intervals. This allows for comparison of the BNB method to the WAAVP, Gamma, Binomial and Asymptotic methods.
Application
Analysis methods
Data derived from the three paired datasets described in section 2 were analysed using the five analytical methods described in section 4 (BNB, WAAVP, Gamma, Binomial, and Asymptotic).
Mebendazole efficacy targets of 70% for hookworm, 95% for A. lumbricoides and 50% for T. trichiura were used, as recommended by the World Health Organisation 30 . There is currently no standard recommendation for an appropriate non-inferiority margin for use with this anthelmintic, so we used an arbitrary value of 0.05 for consistency with efficacy threshold values previously recommended in the veterinary literature 20 . However, a value of e.g. 0.1 is equally justifiable for situations where this would reflect the maximum reduction in efficacy that is clinically acceptable 34 . Depending on the analytical method, either p-values (for the BNB method) or 95% confidence intervals (for other methods) were used to generate a classification for the observed efficacy as previously described.
Analysis results
Estimated efficacies (defined here as arithmetic mean ERR) of 53%, 100% and 49% were calculated for hookworm, A. lumbricoides and T. trichiura, respectively. Estimates of the overdispersion parameters @ 8 and @ A were generated for each dataset using maximum likelihood estimation. These estimates are given along with the pre-and post-treatment mean egg counts and the correlation between pre-and post-treatment counts in Table 1 . Table 1 : Estimates of pre-treatment arithmetic mean, post-treatment arithmetic mean, pre-and posttreatment over-dispersion parameters k1 and k2 and the correlation between pre-and post-treatment data for three intestinal parasites based on samples from 91 children from Pemba Island (Tanzania). These numbers are presented in terms of the raw total egg counts rather than eggs per gram as given by Palmeirim et al. 14 Results from the five analytical methods applied to the three datasets are shown in Table 2 . All methods yielded a classification of reduced efficacy (typology 1) for hookworm: the observed efficacy of 53% being significantly less than the target value of 70%. Confidence intervals were also qualitatively similar between the methods producing 95% confidence intervals, with the exception of the Binomial method, which generates confidence intervals that are spuriously narrow 35 . For A. lumbricoides, the WAAVP, Gamma and Asymptotic methods failed to calculate uncertainty due to the 100% observed reduction. The remaining BNB and Binomial methods both classified the efficacy as adequate (typology 4). For T. trichiura, the inconclusive classification was assigned using all but one of the methods: the observed efficacy of 49% being neither significantly lower than the target value of 50% nor significantly within the margin of equivalence (typology 2).
The only exception was the Binomial method, which classified the efficacy as adequate, again reflecting that this approach overstates the statistical confidence. 
Numerical validation
Validation Methods
The five different statistical methods outlined in section 4 vary in terms of limitations and assumptions, but are sufficiently computationally simple that their relative performance can be assessed using a simulation study. It is therefore useful to undertake a short numerical validation of each of these methods with parameter values similar to those encountered in the example datasets in order to ascertain the type I and type II error rates for the inferiority and non-inferiority tests associated with each method.
Over-dispersed count data were simulated from negative binomial distributions corresponding to the two pre-and post-treatment datasets for each of the three parasites, with simulation parameter values for pre-treatment mean count, k1, k2 and correlation between pre-and post-treatment counts as given in Table 1 . The correlation was simulated by drawing bivariate gamma values using the method described by Nadarajah and Gupta 40 , and subsequently simulating the observed counts using a Poisson variate based on these. It was not possible to calculate k2 or the correlation between paired : ; and S ; for A. lumbricoides due to the 100% observed reduction, so values of k2 = 0.64 k1 and correlation = 0.67 were assumed based on estimates of k2 / k1 and correlation obtained from the other two species. A total of 10,000 replicate pre-treatment datasets were simulated for each parasite, each with corresponding post-treatment datasets using 1,001 different values of r in the set {0.000, 0.001, 0.002, … 0.998, 0.999, 1.000} to represent the full spectrum of possible comparative efficacy values. This exercise was repeated with sample sizes of N = 91 (to match the example dataset), as well as N = 20 and N = 1,000 for comparison. Each of these ~90 million datasets were then analysed with each of the five statistical methods. The frequencies of each individual hypothesis test result were retained along with classification frequencies for each combination of analysis method, simulated parasite parameters, r and sample size. Where a simulated reduction of 100% was obtained, neither hypothesis was assumed to be rejected for the WAAVP, Gamma and Asymptotic methods. The code required to run these simulations, including both data simulation and statistical analysis methods, was implemented in C++ using an Rcpp interface 41 within the "bayescount" package for R 42 .
Validation Results
Generation and analysis of the datasets took approximately 160 µs per N = 20 dataset, 660 µs per N = 91 dataset and 7 ms per N = 1,000 dataset on a five-year-old 3.5GHz Xeon-class workstation.
Profiling of the relevant C++ code involved indicated that the majority of the time was used in simulating the datasets and re-estimating the over-dispersion parameters via maximum likelihood.
The most relevant type I error rates, given our assumed sample size of 91 at simulated efficacy values corresponding to TI (the infimum of the set {! ∈ ℝ | % ≥ ! ≥ 1}) for the inferiority test and TA (the supremum of the set {! ∈ ℝ | 0 ≥ ! > % − '}) for the non-inferiority test, are given in Table 3 . The notional 2.5% type I error rates were generally very similar across the BNB, WAAVP and Gamma methods, although the error rate of the Gamma method exceeded that of the other methods for the non-inferiority test with A. lumbricoides, and the error rate of the BNB method exceeded that of the other methods for the inferiority test with T. trichiura. However, the relatively high error rate associated with the inferiority test for A. lumbricoides is of particular concern for the WAAVP (9.7%), Gamma (8.1%) and BNB (9.4%) methods. As well as focusing on each of the two tests individually, it is also instructive to consider the expected frequency of obtaining each of the four main typologies. These are shown in Figure 2 35 ). However, typology 3 is observed more frequently than typology 2 for all methods at the higher sample size of 1,000 (data not shown); the larger sample size reducing the width of the derived confidence interval and hence reducing the observed occurrence of the 'inconclusive' typology. TI are shown using dashed and solid black vertical lines, respectively, and the x-axis is limited to ± 10 percentage points of these values. The fraction of simulated datasets that could not be analysed using the WAAVP, Gamma and Asymptotic methods due to a 100% observed reduction are shown in orange (a thin vertical stripe close to r = 100%, visible only for Ascaris lumbricoides). 
Discussion
This work provides a theoretically justified statistical framework within which to evaluate the ratio of means between two data series drawn from negative binomial distributions. Our motivating example is in the field of medical parasitology, and we illustrate our approach by analysing three ERR datasets from a single arm of a randomised controlled trial representing hookworm, A.
lumbricoides and T. trichiura egg counts, with A. lumbricoides posing particular statistical challenges due to the observed reduction of 100%. In each case, our framework provides a clearly interpretable and clinically relevant classification for each of the datasets relative to a published target efficacy value. We therefore believe that this framework will be useful within the fields of both medical and veterinary parasitology, as well as other fields where over-dispersed count datasets are commonplace, e.g. occurrence of migraines 3 , falls in elderly patients 4 , and seizures 5, 6 .
Although no similar classification framework currently exists within the medical parasitology literature, a classification framework with similar goals forms part of the current WAAVP guidelines for the detection of anthelmintic resistance in animals 20 . It is instructive to briefly compare the typologies within the framework presented here to the WAAVP classification system, which is based on the three possible outcomes of 'resistance present', 'resistance suspected', or 'susceptible'. The key element of the Coles et al. 20 framework is whether the lower 95% confidence limit for the mean is less than a minimum efficacy value 35 . If this is the case, then the treatment will be described as 'resistance present' if !̂ < E, or 'resistance suspected' if !̂ ≥ E. A lower confidence limit below this minimum efficacy value could reflect resistance, but it could also be driven simply by a small sample size: the strongest interpretation of such an event therefore ought to be that there is no evidence that the treatment is delivering an adequate efficacy. This is a much weaker statement than the recommended classification of the treatment as 'resistance present' or 'resistance suspected', and implies the potential for a great number of false positive conclusions of resistance within the existing literature. As the use of confidence intervals in this framework is not based on a meaningful hypothesis test, the conclusions are not well formulated and the interpretation is unclear. In contrast, one of the important features of the inferiority/non-inferiority framework presented here is the focus on establishing positive evidence for statements made about efficacy, and the explicit acknowledgment of uncertainty, particularly that arising from limited sample sizes. For the interested reader, an interactive tool to explore the consequences of this classification framework is provided at http://www.fecrt.com/framework
Our framework requires two estimates to inform the threshold values used: the target efficacy E and a non-inferiority margin d. In the context of assessing anthelmintic efficacy, the former should be chosen to reflect the expected ERR associated with a population of parasites that are fully susceptible to the anthelmintic in question: we suggest that this value can be drawn from the literature in most cases. The non-inferiority margin should be chosen as the maximum clinically acceptable difference in efficacy from the target 34 , which may vary between different situations and study objectives. In the context of ERR, a value of d = 0.1 rather than 0.05 is equally justifiable if based on suitable clinical reasoning. Another important aspect of non-inferiority testing as implemented in the medical domain is the choice of confidence level 43 . Whereas traditional inferiority and superiority testing is typically carried out with a 5% significance level (95% confidence), non-inferiority testing is frequently carried out with alternative, lower confidence levels such as 90%. The decision to use smaller confidence limits reduces the threshold of evidence required to reject the null hypothesis and accept the non-inferiority of the treatment; this is particularly important where the margin of equivalence is relatively small. Although ERR results have so far been interpreted exclusively using 95% confidence intervals, there is no reason that this flexibility in choice of confidence level should not be utilised. The inter-relatedness of the simultaneous inferiority and non-inferiority tests as presented here also gives rise to an additional and related point of consideration: for the most relevant observed estimates of r, a statistically significant test result (and therefore potential for type I error) can only be observed from one of the two hypothesis tests at a time, i.e. either for the inferiority test when !̂< $ ï or the non-inferiority test when !̂≥ $ ñ . If the parameter range $ ï ≥ !̂> $ ñ (where there is some possibility of obtaining typology 3) is disregarded, these considerations imply that for the most relevant values of !, an alpha value of 5% corresponds to an overall type I error rate of 5%. This choice might therefore be more appropriate than the 2.5% value implied by the current standard use of 95% confidence intervals. Using a higher alpha value would lead to correspondingly higher power, which is of potentially considerable practical benefit. Further work to explore the implications of this would be beneficial: the use of a formal statistical framework such as the one proposed here would be a coherent basis on which to assess such proposals.
In addition to facilitating the interpretation of results following analysis of existing data, the framework developed also allows for the type I and type II error rates of any (computationally simple) statistical method to be quickly and easily quantified. This has been utilised here to show that the Gamma, WAAVP and BNB methods of analysis have broadly equivalent type I and type II error rates for population parameter values relevant to the three datasets presented. However, the extremely high over-dispersion evident in the A. lumbricoides dataset results in estimated type I error rates for the inferiority test using each of these methods that substantially exceed the notional 2.5% values. An important exception to these similarities is seen when high simulated efficacy values are used, when the BNB method has a clear advantage due to its ability to meaningfully analyse datasets with a 100% observed reduction. The potential disadvantage of the BNB method is that it does not produce confidence intervals, although this is not necessarily a disadvantage if the aim is to classify the observed reduction in a manner similar to that presented here. The apparently good performance of the WAAVP and Gamma methods is perhaps surprising given that a normal approximation has previously been shown to be poor for egg count data 37 , but we note that the relatively large sample size and pre-treatment mean egg counts of our example datasets are likely to favour these methods. We therefore recommend the use of either the Gamma, WAAVP or BNB method for analysing similar datasets, with the latter likely to be preferred for lower pre-treatment mean egg counts. Alternatively, a more computationally-intensive method such as MCMC could be used [23] [24] [25] 44 , although we note the relative difficulty in verifying the properties of statistical tests based on MCMC compared to those based on the computationally simpler methods presented here.
For datasets with different expected parameter values, it would seem prudent to undertake a further simulation exercise to verify that the planned statistical method provides valid inference under these conditions: this is likely to be of particular concern for small datasets with relatively high overdispersion. We also recommend that any further development in statistical methods be verified using the same simulation methods based on parameters informed by similarly appropriate data sets.
Although beyond the scope of this paper, a similar simulation approach could be utilised as an aid to designing a prospective study to help determine the appropriate sample size for a given set of parameter values. This aspect of study design is currently largely neglected within the parasitology community due to the lack of widely available methods, although simulation studies have previously been published for a given set of parameter values 8, 21, 23, 35, 45 and methods are available for testing that r > 0% 7, 11, 12 . Where each of the two hypothesis tests are considered separately, the results could be interpreted as a standard analysis of statistical power. However, when combining the results of the two related hypothesis tests into a single typology classification, we suggest that something similar to the typology plot given in Figure 2 
Statistical Appendix
This appendix contains the derivation of the beta negative binomial (BNB) method presented in "A hypothesis testing framework for the ratio of means of two negative binomial distributions:
classifying the efficacy of anthelmintic treatment against intestinal parasites" by Denwood et al.
Background
The efficacy r, defined as the ratio of the means of the two count distributions xi and yi, is typically the statistic of interest. However, within a hypothesis testing framework, we may also usefully consider the distribution of a sufficient statistic for the mean of one of the count distributions integrated over all possible values of an equivalent statistic for the other count distribution. For this derivation, we assume that both count distributions xi and yi follow negative binomial distributions, and that the over-dispersion parameters k1 and k2 are either known or can be estimated from the data. We show here how a beta negative binomial compound distribution can be used to describe the distribution of yi under one or more null hypotheses, with parameters that can be derived from the observed data xi and given parameter values r, k1 and k2.
Estimation of the expectation for µ2
We use the formulation of the negative binomial distribution defined as the number of successes before a given number of failures, with probability of success p, which is generalised to allow any strictly positive value of number of failures. This has the same distribution function as a gamma-Poisson distribution, with shape parameter k representing the number of failures, and mean number of successes given by µ = #$ %&# . We assume that k1 and k2 are known, while we treat p1 as a random variable with properties depending on the observed xi. In the following, we use a Bayesian framework to fully describe the posterior distribution of p1 using a conjugate prior distribution.
Specifically, we use a beta distribution as the conjugate prior for the negative binomial (given fixed k), with posterior parameters: , 1 − D).
We can then derive the uncertainty distribution for the post-treatment probability of success p2 by treating it as a non-linear function of the beta-distributed pre-treatment probability of success p1.
Expressing µ2 as a function of p1, k1, k2 and r, it can be seen that:
Rearranging yields p2 as a non-linear function g of p1, r, k1 and k2: There are two options to yield the full distribution of the uncertainty in p2 given the beta conjugate prior for p1 (and fixed k1, k2, r):
1. Numerical integration based on a sample of realisations of p1 from Beta(α1, β1) with subsequent functional transformation, which yields a Monte Carlo approximation to the distribution of p2.
2. Using an approximation based on the delta method to approximate the mean and variance of the non-linear, smooth transformation ' F = H(' % ; 9 % , 9 F , D), given the fixed values and the moments of the random variable p1.
Given that the primary objective here is to provide a method of performing power calculations, we prefer the computationally simpler method (2), and give the derivation of this below. However, we acknowledge the utility of numerical integration methods, and have also used these to verify that the approximations required in the delta method are justified.
Delta method approximation
The mean of the distribution of H(' % ; 9 % , 9 F , D) conditional on the Beta(α1, β1) distribution of the random variable p1, is empirically well estimated by the first 2 terms of the Taylor series expansion: The required 1st-4th partial derivatives of g with respect to p1 given fixed and strictly positive k1, k2, r can readily be derived as: All of the required quantities can therefore be easily calculated so that the mean and variance of the uncertainty distribution describing p2 (and therefore also that for ∑ < 6 j L 68% ) can be derived. Although we have not defined the functional form of this distribution of uncertainty for p2, the distribution is bounded at [0, 1] and numerical integration of the transformation empirically approximates a beta distribution within sensible parameter bounds. We therefore describe the distribution of uncertainty for p2 using a Beta(α2, β2) distribution with parameters derived from the mean and variance of this distribution as defined above.
Distribution of the test statistic
In order to implement the statistical tests, a sufficient statistic derived from < 6 must be compared to the distribution of the same statistic under the null hypothesis. We note that the sum of < 6 is distributed according to: ∑ < 6 j L 68% ∼ NegBin(n F 9 F , ' F ).
Hypothesis testing for the ratio of negative binomial distributions: statistical appendix 4
The quantity N2k2 is assumed to be fixed, and p2 is described by a Beta(α2, β2) distribution, conditional on the observed xi, fixed quantities k1 and k2, prior parameters α0 and β0, and an assumed fixed value for the efficacy r that corresponds to the efficacy specified under the null hypothesis. We can therefore describe the expected distribution of the test statistic using a beta negative binomial distribution, defined as s successes before a given number of failures for consistency with our use of the negative binomial distribution, with probability mass function given by:
'(o; α F , β F , n F 9 F ) = Γ(n F 9 F + o) 9! Γ(n F 9 F ) B(β F + n F 9 F , α F + o) B(β F, , α F ) ,
where B is the beta function. The observed test statistic ∑ < 6 j L 68%
can be evaluated with respect to this beta negative binomial distribution to derive the associated p-value.
